Neurotrophic factor therapy for Parkinson's disease: past, present and future

por Sullivan, Aideen M., O’Keeffe, Gerard W.
Publicado 2016

Neurotrophic factors: from neurodevelopmental regulators to novel therapies for Parkinson's disease

por Hegarty, Shane V., O’Keeffe, Gerard W., Sullivan, Aideen M.
Publicado 2014

The Epigenome as a therapeutic target for Parkinson's disease

por Hegarty, Shane V., Sullivan, Aideen M., O'Keeffe, Gerard W.
Publicado 2016

Class-Specific Histone Deacetylase Inhibitors Promote 11-Beta Hydroxysteroid Dehydrogenase Type 2 Expression in JEG-3 Cells

por Togher, Katie L., Kenny, Louise C., O'Keeffe, Gerard W.
Publicado 2017

Targeting transcriptional regulators to regenerate midbrain dopaminergic axons in Parkinson's disease

por Hegarty, Shane V., Sullivan, Aideen M., O’Keeffe, Gerard W.
Publicado 2017

Protocol for evaluation of neurotrophic strategies in Parkinson’s disease-related dopaminergic and sympathetic neurons in vitro

por Hegarty, Shane V., Sullivan, Aideen M., O’Keeffe, Gerard W.
Publicado 2016

Inhibition of miR-181a promotes midbrain neuronal growth through a Smad1/5-dependent mechanism: implications for Parkinson’s disease

por Hegarty, Shane V., Sullivan, Aideen M., O’Keeffe, Gerard W.
Publicado 2018

Targeting bone morphogenetic protein signalling in midbrain dopaminergic neurons as a therapeutic approach in Parkinson's disease

por O'Keeffe, Gerard W., Hegarty, Shane V., Sullivan, Aideen M.
Publicado 2017

Characterisation of the consequences of maternal immune activation on distinct cell populations in the developing rat spinal cord

por Anderson, Rebecca C., O'Keeffe, Gerard W., McDermott, Kieran W.
Publicado 2022

The class II histone deacetylases as therapeutic targets for Parkinson’s disease

por Mazzocchi, Martina, Collins, Louise M, Sullivan, Aideen M., O'Keeffe, Gerard W.
Publicado 2020

Transplantation of novel human GDF5-expressing CHO cells is neuroprotective in models of Parkinson's disease

por Costello, Daniel J, O'Keeffe, Gerard W, Hurley, Fiona M, Sullivan, Aideen M
Publicado 2012

The potential of bone morphogenetic protein 2 as a neurotrophic factor for Parkinson's disease

por Goulding, Susan R., Sullivan, Aideen M., O'Keeffe, Gerard W., Collins, Louise M.
Publicado 2020

Mid-gestation cytokine profiles in mothers of children affected by autism spectrum disorder: a case–control study

por Carter, Michael, Casey, Sophie, O’Keeffe, Gerard W., Gibson, Louise, Murray, Deirdre M.
Publicado 2021

Placental FKBP51 mediates a link between second trimester maternal anxiety and birthweight in female infants

por Togher, Katie L., O’Keeffe, Gerard W., Khashan, Ali S., Clarke, Gerard, Kenny, Louise C.
Publicado 2018

Editorial: The Role of Stem Cells, Epigenetics and MicroRNAs in Parkinson's Disease

por Hegarty, Shane V., Green, Holly F., Niclis, Jonathan, O'Keeffe, Gerard W., Sullivan, Aideen M.
Publicado 2020

Growth differentiation factor 5: a neurotrophic factor with neuroprotective potential in Parkinson’s disease

por Goulding, Susan R., Anantha, Jayanth, Collins, Louise M., Sullivan, Aideen M., O'Keeffe, Gerard W.
Publicado 2021

Maternal Immune Activation and Interleukin 17A in the Pathogenesis of Autistic Spectrum Disorder and Why It Matters in the COVID-19 Era

por Carter, Michael, Casey, Sophie, O'Keeffe, Gerard W., Gibson, Louise, Gallagher, Louise, Murray, Deirdre M.
Publicado 2022

Diet quality, sleep and quality of life in Parkinson’s disease: a cross-sectional study

por Dunk, Danielle, Mulryan, Philip, Affonso, Sean, O’Keeffe, Gerard W., O’Keeffe, Majella, Sullivan, Aideen M.
Publicado 2022

Regulation of neurite growth by tumour necrosis superfamily member RANKL

por Gutierrez, Humberto, Kisiswa, Lilian, O'Keeffe, Gerard W., Smithen, Matthew J., Wyatt, Sean, Davies, Alun M.
Publicado 2013

The dietary flavonoid isoliquiritigenin is a potent cytotoxin for human neuroblastoma cells

por Alshangiti, Amnah M., Togher, Katie L., Hegarty, Shane V., Sullivan, Aideen M., O’Keeffe, Gerard W.
Publicado 2019